Trial · NCT07231523
EFG vs IVIG in TAMG
NCT07231523, Phase 3, Not yet recruiting, Shanghai Zhongshan Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. EFG vs IVIG in TAMG. Trials, record NCT07231523. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07231523
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- EFG vs IVIG in TAMG
- NCT number
- NCT07231523
- Status
- Not yet recruiting
- Phases
- Phase 3
- Enrollment
- 64 participants, estimated
- Lead sponsor
- Shanghai Zhongshan Hospital
- Conditions
- Efgartigimod, Intravenous Immunoglobulin, Myasthenia Gravis Associated With Thymoma
- Interventions
- Efgartigimod + Thymectomy, Intravenous immunglobulin + Thymectomy
- First posted
- 2025-11-17
- Last updated
- 2025-11-17
Source ClinicalTrials.gov
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Quantitative Myasthenia Gravis (QMG) reduction | From baseline to 2 weeks postoperatively | The total QMG score ranges from 0 to 39, with higher scores indicating more severe condition. |
| Secondary | Myasthenia Gravis Activities of Daily Living (MG-ADL) reduction | From baseline to 2 weeks postoperatively | The total MG-ADL score ranges from 0 to 24, with higher scores indicating more severe condition |
| Secondary | Myasthenia Gravis Composite (MGC) reduction | From baseline to 2 weeks postoperatively | The total MGC score ranges from 0 to 50, with higher scores indicating more severe condition. |
| Secondary | QMG change (1 day preoperatively) | From baseline to 1 day preoperatively | The change in the QMG score from baseline to 1 day preoperatively |
| Secondary | QMG change (1 week postoperatively) | From baseline to 1 week postoperatively | The change in the QMG score from baseline to 1 week postoperatively |
| Secondary | QMG change (1 month postoperatively) | From baseline to 1 month postoperatively | The change in the QMG score from baseline to 1 month postoperatively |
| Secondary | QMG change (2 months postoperatively) | From baseline to 2 months postoperatively | The change in the QMG score from baseline to 2 months postoperatively |
| Secondary | MG-ADL change (1 day preoperatively) | From baseline to 1 day preoperatively | The change in the MG-ADL score from baseline to 1 day preoperatively |
| Secondary | MG-ADL change (1 week postoperatively) | From baseline to 1 week postoperatively | The change in the MG-ADL score from baseline to 1 week postoperatively |
| Secondary | MG-ADL change (1 month postoperatively) | From baseline to 1 month postoperatively | The change in the MG-ADL score from baseline to 1 month postoperatively |
1 to 10 of 27Source ClinicalTrials.gov
See all 27 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07231523
GET https://conductscience.org/api/trials/v1/NCT07231523/registered?page=2